Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Wellbutrin
Wellbutrin
Existing Drug Combo Shows Potential for First Meth Addiction Treatment
BioSpace
Fri, 01/15/21 - 10:07 am
meth addiction
GSK
Wellbutrin
Wellbutrin's Collapse: An Omen For Valeant Shareholders
Seeking Alpha
Sat, 12/17/16 - 12:10 pm
Wellbutrin
Valeant Pharmaceutcals
Valeant: Another Philidor?
Seeking Alpha
Tue, 10/18/16 - 09:40 pm
Valeant Pharmaceuticals
Philidor Rx
Wellbutrin
GlaxoSmithKline in $105 mln settlement with U.S. states over marketing
Yahoo/Reuters
Wed, 06/4/14 - 01:40 pm
GSK
Advair
Paxil
Wellbutrin
off-label
FDA Pulls One Generic Form of Wellbutrin Off the Market
Medline Plus
Fri, 12/7/12 - 10:44 am
FDA
generics
Wellbutrin
antidepressants
Teva
Impax Labs
Generic antidepressant not equivalent to original Wellbutrin -FDA
Reuters
Sun, 10/7/12 - 11:51 am
Wellbutrin
GSK
generics
Impax Laboratories
Teva Pharmaceuticals
Glaxo Case Pushes U.S. Health Settlements to $6.6 Billion
Bloomberg
Thu, 09/27/12 - 10:36 am
GSK
settlements
Paxil
Wellbutrin
Pfizer’s Zyvox and Antidepressants May Be Fatal Combination
Bloomberg
Tue, 07/26/11 - 04:36 pm
Pfizer
antidepressants
Zyvox
antibiotics
Pristiq
Eli Lilly
Zoloft
Cymbalta
GSK
Paxil
Wellbutrin
Judge won't toss suit over Wellbutrin generics
Fierce Pharma
Fri, 05/28/10 - 10:49 am
Wellbutrin
Teva Pharmaceuticals
generics
GSK
lawsuits
Impax
FDA approves Mylan's drug applications
Bizjournals.com
Mon, 04/12/10 - 12:12 pm
FDA
Mylan
antihypertensives
generics
Merck
Wellbutrin
GSK
Hyzaar
Will generic Wellbutrin live up to brand?
Fierce Pharma
Mon, 01/25/10 - 12:38 pm
Wellbutrin XL
generics
GSK
Teva Pharmaceuticals
Biovail
Wellbutrin
Biovail gains US rights to Wellbutrin XL from Glaxo after antitrust review period ends
Yahoo/AP
Fri, 05/15/09 - 07:59 am
GSK
Wellbutrin
Biovail
antidepressants
Glaxo Sells U.S. Rights to Wellbutrin XL Drug to Biovail for $510 Million
Bloomberg
Wed, 05/6/09 - 06:14 am
GSK
Biovail
Wellbutrin